Home › Triple-Negative Breast Cancer › Florida › Sarasota
Triple-Negative Breast Cancer clinical trials in Sarasota, FL
8 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Sarasota (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
Study of AVZO-021 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, Sarasota
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- SCRI Florida Cancer Specialists - Sarasota, Sarasota
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecruitingPhase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
RecruitingPhase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecruitingPhase 1
- Florida Cancer Specialists, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RecruitingPhase 1
- Dren Investigational Site, Sarasota
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Sarasota
- Metastatic Cancer19 studies
- Non-Small Cell Lung Cancer17 studies
- Colorectal Cancer16 studies
- Ovarian Cancer16 studies
- Endometrial Cancer14 studies
- Breast Cancer12 studies
- Cancer (all types)11 studies
- Lung Cancer7 studies
- Pancreatic Cancer7 studies
- Atrial Fibrillation7 studies
- Prostate Cancer6 studies
- Steatotic Liver Disease6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.